Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Actelion
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with ES (including those with Down Syndrome) having completed the double-blind AC-055-305 / MAESTRO study as scheduled, i.e., who remained in the double-blind study up to Week 16 (whether or not they were still taking study drug at the end of this period).
You may not be if
Subjects who prematurely discontinue double-blind study drug during the AC-055-305 / MAESTRO study due to:
an AE assessed as related to the use of study drug,
or elevated liver tests (related or unrelated to study drug).
